Management of Hyperbilirubinemia in Neonates

Initial Assessment and Measurement

The American Academy of Pediatrics recommends measuring the total serum bilirubin (TSB) immediately and interpreting it according to the infant's age in hours using hour-specific nomograms to determine if phototherapy or more aggressive intervention is needed 1
Obtain a TSB or transcutaneous bilirubin (TcB) measurement on any 5-day-old infant who appears jaundiced, as visual estimation is unreliable, particularly in darkly pigmented infants 1
Interpret all bilirubin levels according to the infant's exact age in hours (120 hours for a 5-day-old), not just days, as thresholds vary significantly by hour 1

Infants with gestational age <38 weeks require more aggressive treatment than those ≥38 weeks, according to the American Academy of Pediatrics 3, 4
Hemolytic disease, such as ABO/Rh incompatibility, positive Coombs test, or G6PD deficiency, particularly in infants of Mediterranean, Middle Eastern, African, or Asian descent, is a significant risk factor 1, 2
Exclusively breastfed infants with poor intake or weight loss >12% are at higher risk 3, 4
Serum albumin <3.0 g/dL lowers the threshold for phototherapy 4, 5

For a 5-day-old with significant jaundice, obtain TSB and direct (or conjugated) bilirubin levels, blood type (ABO, Rh) and direct antibody test (Coombs'), complete blood count with differential and smear, reticulocyte count, and G6PD testing as indicated 3, 4
Serum albumin should be measured if levels are approaching exchange transfusion thresholds 4, 5

Initiate intensive phototherapy based on hour-specific nomograms that account for gestational age and risk factors, as recommended by the American Academy of Pediatrics 3, 4
For a 5-day-old (120 hours) term infant without risk factors, phototherapy is typically indicated when TSB reaches approximately 15-18 mg/dL, but this threshold is lower for infants with risk factors 3, 4
Do not subtract the direct bilirubin from the total bilirubin when making treatment decisions 3, 4

Feed every 2-3 hours (breast milk or formula) to maintain hydration and promote bilirubin excretion 3, 4
Recheck TSB based on the level, with more frequent checks for higher levels 3, 4
Discontinue phototherapy when TSB falls below 13-14 mg/dL 3, 4
Consider rebound check 24 hours after discontinuation, particularly if the cause was hemolytic disease 3, 4

If TSB ≥25 mg/dL (428 μmol/L) at any time, this is a medical emergency requiring immediate admission to a hospital pediatric service for intensive phototherapy 3, 4
Obtain type and crossmatch for possible exchange transfusion 3, 4
Administer intravenous immunoglobulin 0.5-1 g/kg over 2 hours for isoimmune hemolytic disease with TSB rising despite intensive phototherapy or within 2-3 mg/dL of exchange level 3, 4, 5

Exchange transfusion should be performed only by trained personnel in a neonatal intensive care unit with full monitoring and resuscitation capabilities 3, 4
Thresholds for exchange transfusion are based on hour-specific nomograms, gestational age, and the bilirubin/albumin ratio 4, 5

Continue breastfeeding if possible even during phototherapy, as interrupting breastfeeding increases the risk of early discontinuation 5
If weight loss exceeds 12% or there is clinical/biochemical evidence of dehydration, supplement with formula or expressed breast milk 3, 4
If oral intake is inadequate, provide intravenous fluids 3, 4